NuCana NCNA 深 沪
交易中 10-06 10:14:33 美东时间
1.085
+0.025
+2.36%
华盛通- 最 高1.90
- 今 开1.08
- 成交量 1.07万股
- 最 低 0.9484
- 昨 收 1.06
- 总市值 5.66万
- 52周最高 5.65
- 市盈率 静 --
- 换手率 20.59%
- 52周最低 0.9484
- 委 比 -93.91%
- 总股本 5.22万
- 历史最高 160000.00
- 量 比 0.70
- 振 幅 89.77%
- 历史最低 0.9484
- 每 手 1
- 风险率 1.17%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多NuCana Appoints Ian Webster CFO, Effective Immediately
NuCana plc (NASDAQ: NCNA) ("NuCana" or the "Company"), a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer, announced the appointment of Ian Webster
06-01 20:11
NuCana Appoints Theresa Bruce COO, Effective Jan. 1
NuCana plc (NASDAQ: NCNA) ("NuCana" or the "Company"), a clinical-stage biopharmaceutical company focused on improving treatment outcomes for patients with cancer, announced the appointment of Theresa Bruce as Chief
01-06 21:01
Why Telesis Bio Shares Are Trading Higher By Around 110%; Here Are 20 Stocks Moving Premarket
Shares of Telesis Bio, Inc. (NASDAQ:TBIO) rose sharply in today's pre-market tr...
2024-09-26 18:31
NuCana Announces Grant Of Composition-Of-Matter Patent For NUC-7738 In The U.S.
NuCana plc (NASDAQ:NCNA) announced the issuance of a new patent by the United States Patent and Trademark Office (USPTO) covering NUC-7738's composition of matter. This patent (US12,054,510) is expected to serve as a key
2024-09-26 04:03
Crude Oil Surges Over 1%; Instil Bio Shares Plunge
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite fall...
2024-09-17 00:31
Market-Moving News for September 16th
NCNA: 282% | NuCana Presented Final Data From Phase 2 Nutide:701 Study At ESMO Congress On NUC-7738 In Combination With Pembrolizumab For Patients With Metastatic Melanoma Who Were Refractory To Or Had Relapsed On
2024-09-16 20:08
Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket
Shares of Exicure, Inc. (NASDAQ:XCUR) rose sharply in today's pre-market tradin...
2024-09-16 18:07
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Theriva Biologics (AMEX:TOVX) shares moved upwards by 34.2% to $6.31 during Monday's pre-market session. The market value of their outstanding shares is at $6.3 million. Emergent BioSolutions (NYSE:EBS) shares rose 17.62% to $10.48. The market value of their outstanding shares is at $549.1 m...
2024-09-02 20:05
